Skip to content

Is Patients With Pulmonary Disease Benefit a Program With Yogic Exercises?

Subjective and Objective Effects After Yogic Exercises

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02233114
Enrollment
40
Registered
2014-09-08
Start date
2015-01-31
Completion date
2016-01-31
Last updated
2016-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, COPD

Brief summary

Is Yogic Exercises (12 weeks) increasing respiratory function, functional capacity and quality of life in patients with obstructive lung diseases. With follow up after 6 months.

Detailed description

Is Yogic Exercises increasing respiratory function in patients with obstructive lung diseases. Will YE improve respiratory muscle strength, functional capacity, inspiratory and expiratory pressure, lung function, perceived dyspnea, dyspnea-related distress (DD), less frequency of dyspnea and heart rate variability in patients with pulmonary disease. Qualitative content analysis will be performed on approximately 15 interviews with patients participated in the yoga group about their experiences and their benefits perceived/experienced of the yogic exercises We want to try YE as an alternative treatment in patients with mild to severe pulmonary disease.

Interventions

OTHERYogic exercises

Yogic exercises (YE) - 2 hours per week, 1h in each session

OTHERPhysiotherapy

Physiotherapy (low intensity cardiovascular training and strength training) - 2 hours per week, 1 h in each session

Sponsors

Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
35 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Mild to severe pulmonary obstructions according to GOLD 1-3 (Global Initiative for Chronic Obstructive Lung Disease), * FEV (forced expiratory volume) in one second (FEV1) % of predicted respiratory function (30% ≤ FEV1 ≤ 90%) * FEV1/FVC \< 0.70 (\<65 over 65 yrs). \*FVC=forced vital capacity

Exclusion criteria

* Severe neurological, orthopedic or rheumatologic injuries * Severely decreased thorax mobility and lung function. * Severe lung diseases * Other chronic diseases that will interfere with performance. * Under 200 meters on the 6MWT * Acute dyspnea * Surgery within 6 months * Medication affecting attention, sudden change of medication.

Design outcomes

Primary

MeasureTime frameDescription
Dyspnea related distress (DD)Patients will be followed 10-12 weeks, with follow-up after 6 months
Functional capacityPatients will be followed 10-12 weeks, with follow-up after 6 months6 minutes Walking test

Secondary

MeasureTime frameDescription
Respiration ratePatients will be followed 10-12 weeks, with follow-up after 6 monthsMeasured manually
CRQ, Chronic respiratory disease questionnairePatients will be followed 10-12 weeks, with follow-up after 6 months
VAS- scale - perceived healthPatients will be followed 10-12 weeks, with follow-up after 6 monthsScoring between 0 (worst possible) and 10 (best possible)
Maximal inspiratory and maximal expiratory pressurePatients will be followed 10-12 weeks, with follow-up after 6 months
Perceived stressPatients will be followed 10-12 weeks, with follow-up after 6 monthsWill be measured using PSS-14 scale
Sleep qualityPatients will be followed 10-12 weeks, with follow-up after 6 monthsMeasured with Pittsburgh sleep questionnaire index scale
Anxiety and depressionPatients will be followed 10-12 weeks, with follow-up after 6 monthsMeasured with HADS-scale
Self rated healthPatients will be followed 10-12 weeks, with follow-up after 6 months
Subjective complaints (perceived symptoms)Patients will be followed 10-12 weeks, with follow-up after 6 months
Blood pressurePatients will be followed 10-12 weeks, with follow-up after 6 months
Spirometry, Vital capacityPatients will be followed 10-12 weeks, with follow-up after 6 months
Health behaviourPatients will be followed 10-12 weeks, with follow-up after 6 monthsMeasured with public health questionnaire (Folkhälsoenkäten in Swedish)
Exercise diaryPatients will be followed 10-12 weeks, with follow-up after 6 months
Spirometry, forced vital capacity (FVC)Patients will be followed for 10-12 weeks, with follow-up after 6 months
Spirometry, Forced expiratory volumePatients will be followed for 10-12 weeks, with follow-up after 6 months
Spirometry, Forced expiratory volume in one second (FEV1)Patients will be followed for 10-12 weeks, with follow-up after 6 months
Spirometry, Ratio between forced expiratory volume in 1 second and forced vital capacityPatients will be followed for 10-12 weeks, with follow-up after 6 months
Spirometry, peak expiratory flow (PEF)Patients will be followed for 10-12 weeks, with follow-up after 6 months
InsomniaPatients will be followed for 10-12 weeks, with follow-up after 6 monthsMeasured with insomnia index scale
Heart rate variabilityPatients will be followed for 10-12 weeks, with follow-up after 6 monthsMeasured with Polar heart rate monitor
Qualitative content analysisAfter Yoga intervention - one interview, with follow-up after 6 monthsInteviews with participants in yoga Group, and at follow-up also physiotherapy group
Weight and heightPatients will be followed 10-12 weeks, with follow-up after 6 months
Oxygen saturation (periphery)Patients will be followed 10-12 weeks, with follow-up after 6 months

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026